How Much Does a Manufacturing Startup Cost to Launch?

Real SBA lending data, current equipment and construction price trends, and the exact federal loan ceilings that bracket a new factory's budget.

Real SBA lending data, current equipment and construction price trends, and the exact federal loan ceilings that bracket a new factory's budget.

Anthropic submitted its draft S-1 to the SEC confidentially in June, yet its figures keep appearing in the press. How the nonpublic review process works, the 15-day rule before a roadshow, and what founders should expect if they file the same way.

About 80% of Anthropic’s reported $518 billion in compute commitments is either locked in or payable whether or not the capacity is used, according to reports of its draft prospectus. What take-or-pay contracts mean for the books, and what founders signing committed-spend deals can learn.

Anthropic described an adjusted profit to IPO investors less than a week before reports of its draft prospectus revealed $80.7 billion of GAAP losses for the half. Both can be true. Here is how founders can report adjusted numbers honestly, and the SEC rules that apply once a company files to go public.

Two unnamed customers produced about a fifth of Anthropic’s first-half 2026 revenue, The Wall Street Journal reported from a draft prospectus. Here is how the disclosure works, why contract terms matter as much as percentages, and what founders can track long before an IPO.

A $72 billion accounting charge drove most of Anthropic’s reported first-half loss, and none of it was cash. The cause is how convertible notes are measured at fair value. Here is how the rules work, the choices founders make at issuance, and the questions to settle early.

The evidence splits by role: friends make the least stable cofounders, while a trusted referral of a stranger keeps nearly all of the upside.

Work out your next startup hire from runway and Series A milestones, not headcount targets — plus the roles that reliably backfire early.

A practical framework for choosing between part-time and full-time finance leadership, based on the shape of the work rather than headcount.

Seed investors now weigh clinical proof and payer clarity against a market where AI-enabled startups draw the majority of the funding.